InsiderFlow

GENB

Generate Biomedicines, Inc.$10.51-1.56 (-12.97%)
Prev Close$12.07·MCap$1.82B·P/E—·Vol1.03M·Yield—
▲

Buys (12M)

5

$25.29M

▼

Sells (12M)

1

$184.7K

◆

Net Activity

Net Buyer

$25.11M

●

Active Insiders

6

last 12 mo

Over the past 12 months, insider activity at Generate Biomedicines, Inc. (GENB) has been dominated by buying, with 5 insider purchases totaling $25.29M and 1 insider sale totaling $184.7K. The most recent insider transaction was by ARNOLD FRANCES (director), who sold $184.7K worth of shares on Nov 4, 2026. Generate Biomedicines, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.82B.

GENB Insider Trading Activity

DateInsiderTypeValue
Nov 4, 2026 ARNOLD FRANCESSell$184.7K
Mar 6, 2026 Nally MichaelBuy$240.0K
Mar 2, 2026 AFEYAN NOUBARBuy$25.00M1.2% OS
Mar 2, 2026 Grous BethBuy$4.8K
Mar 2, 2026 Mendillo Jane LBuy$24.0K
Mar 2, 2026 Silvers JasonBuy$24.0K

GENB Insider Buying Activity

The following table shows recent insider purchases of Generate Biomedicines, Inc. (GENB) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Mar 6, 2026 Nally MichaelBuy$240.0K
Mar 2, 2026 AFEYAN NOUBARBuy$25.00M1.2% OS
Mar 2, 2026 Grous BethBuy$4.8K
Mar 2, 2026 Mendillo Jane LBuy$24.0K
Mar 2, 2026 Silvers JasonBuy$24.0K

GENB Insider Selling Activity

The following table shows recent insider sales of Generate Biomedicines, Inc. (GENB) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Nov 4, 2026 ARNOLD FRANCESSell$184.7K

GENB Insiders

ARNOLD FRANCES

director

Sold $184.7K
1 tradesLast: Nov 4, 2026
Nally Michael

Chief Executive Officer

Bought $240.0K
1 tradesLast: Mar 6, 2026
Grous Beth

Chief People Officer

Bought $4.8K
1 tradesLast: Mar 2, 2026
Mendillo Jane L

Bought $24.0K
1 tradesLast: Mar 2, 2026
Silvers Jason

President & CFO

Bought $24.0K
1 tradesLast: Mar 2, 2026
AFEYAN NOUBAR

Bought $25.00M
1 tradesLast: Mar 2, 2026